Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can ultrasound match X-Ray guidance for back pain injections?

NCT ID NCT07791108

Symptom relief Sponsor: Allied Hospital Faisalabad Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests whether ultrasound-guided steroid injections into the sacroiliac joint work as well as the standard X-ray-guided method for people with sacroiliitis, a cause of low back and buttock pain. Researchers will compare how often the injection lands correctly, how much pain drops, and how much daily function improves. Adults aged 18 to 70 with a clinical diagnosis of sacroiliitis can join. The goal is to see if a radiation-free imaging option can deliver the same relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Steroid injection (triamcinolone acetonide with bupivacaine) into the sacroiliac joint, guided by ultrasound or fluoroscopy
What this could lead to
If ultrasound guidance works as well as fluoroscopy, it could offer a safer, more accessible option for relieving sacroiliitis pain without radiation exposure.
What could go wrong
This is a single-center trial, and results may not apply broadly. The injection carries risks like infection, bleeding, or temporary pain flare, and pain relief may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 176 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-70 years * Both sexes * Clinical diagnosis of sacroiliitis Exclusion Criteria: * Prior SI joint injection in the past 12 months * Contraindication to corticosteroid injection (systemic infection, local infection, bleeding diathesis, uncontrolled diabetes with HbA1c \>9%, allergy to contrast or steroid) * Radicular or neurogenic pain attributable to lumbar spine or hip pathology * Pregnancy or breastfeeding * Severe osteoarthritis or fusion of the SI joint on imaging * Systemic rheumatologic disease requiring systemic biologic therapy (unless stable for \>6 months)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sacroiliitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritis, sacroiliac Sacroiliitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sacroiliitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Allied Hospital Faisalabad

    Faisalābad, Punjab Province, 38000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.